Applied Therapeutics's total assets for Q3 2024 were $106.57M, a decrease of -16.60% from the previous quarter. DE:2UV total liabilities were $100.67M for the fiscal quarter, a 81.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.